88 results
8-K
EX-10.6
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization and (iv … by, the Company or the Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent
8-K
EX-10.2
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets … to information supplied by, the Company or the Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity
8-K
EX-10.4
3hydi8chyohe1f fjhr7
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.3
40xd44tk
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.1
5om 76yit5
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.2
d5upu3di5 rw9dsx6
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
3982891j
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
x8nio3twt93zt7hqgqmn
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.4
m4ipxv
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-99.1
4mjlnrpe64 7506ck
5 Oct 23
Index to Financial Statements
5:12pm